Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,514 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,514 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,514 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,514 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,514 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,514 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,514 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Jan 2026
Ronald Greer Woodruff EVP Safety, ESG, Maintenance
Sold at will
$287.94K 1,391 at 207.00
25.7%
Not planned
21 Jan 2026
Sam D. Brown SEVP, Chief Banking Officer
Sold on a plan
$182.86K 5,151 at 35.50
8.8%
Planned (10b5-1)
21 Jan 2026
Angelo P Lopresti SVP, Secretary & Gen Counsel
Sold on a plan
$127.50K 1,500 at 85.00
2.5%
Planned (10b5-1)
21 Jan 2026
Olivia Nottebohm Chief Operating Officer
Sold on a plan
$120.10K 4,612 at 26.04
1.0%
Planned (10b5-1)
21 Jan 2026
Kelly Costanza Chief People Officer
Sold at will
$114.73K 1,702 at 67.41
1.4%
Not planned
21 Jan 2026
Nick Rosenberg Executive Vice President
Sold on a plan
$112.77K 1,250 at 90.21
4.6%
Planned (10b5-1)
21 Jan 2026
Jeff Cislini General Counsel
Sold on a plan
$104.96K 908 at 115.60
1.9%
Planned (10b5-1)
21 Jan 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$102.93K 438 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Cynthia L Tregillis Chief Legal Officer & Corp Sec
Sold on a plan
$102.36K 447 at 229.00
0.3%
Planned (10b5-1)
21 Jan 2026
Michael Wayne Domino Jr. President, DTR Division
Sold on a plan
$99.98K 24,996 at 4.00
1.7%
Planned (10b5-1)
21 Jan 2026
Steven Yi See Remarks
Sold on a plan
$88.18K 8,000 at 11.02
0.3%
Planned (10b5-1)
21 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$79.67K 339 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Casey O'Connor Chief Legal Officer
Sold on a plan
$73.97K 13,852 at 5.34
2.5%
Planned (10b5-1)
21 Jan 2026
Kenneth Robert Bertram CLO & Secretary
Sold at will
$72.40K 1,074 at 67.41
2.1%
Not planned
21 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$68.86K 293 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Theodoros Xenohristos Chief Concept Officer
Sold at will
$65.05K 965 at 67.41
0.3%
Not planned
21 Jan 2026
Christopher Vanderhook Chief Operating Officer · indirect
Sold on a plan
$60.30K 4,926 at 12.24
65.7%
Sold half or more
21 Jan 2026
Jay S Stout Chief Technology Officer
Sold at will
$51.46K 1,977 at 26.03
1.0%
Not planned
21 Jan 2026
J. Jefferson Smith Chief Research Officer
Sold on a plan
$41.11K 10,200 at 4.03
8.5%
Planned (10b5-1)
21 Jan 2026
Zachary Roberts EVP of R&D
Sold at will
$40.98K 26,269 at 1.56
4.1%
Not planned
21 Jan 2026
Dario Scimeca General Counsel and Secretary
Sold on a plan
$35.68K 8,854 at 4.03
16.5%
Planned (10b5-1)
21 Jan 2026
Shane Thomas Gleason Chief Commercial Officer
Sold at will
$28.55K 17,593 at 1.62
1.5%
Not planned
21 Jan 2026
Brian Cree President
Sold on a plan
$28.36K 1,440 at 19.69
0.3%
Planned (10b5-1)
21 Jan 2026
Peter Platzer Executive Chairman
Sold on a plan
$21.79K 1,801 at 12.10
0.1%
Planned (10b5-1)
21 Jan 2026
Charles Peter Kirol Chief Operating Officer
Sold on a plan
$19.90K 3,399 at 5.85
4.2%
Planned (10b5-1)
21 Jan 2026
Randall Moreadith Chief Scientific Officer
Sold on a plan
$6.00K 2,000 at 3.00
100%
Sold half or more
21 Jan 2026
John L. Brottem General Counsel
Sold at will
$5.91K 1,180 at 5.01
3.2%
Not planned
21 Jan 2026
Marc Nash EVP Operations R&D & Service
Sold at will
$4.88K 980 at 4.98
2.3%
Not planned
21 Jan 2026
Eric Siemers Chief Medical Officer
Sold at will
$4.20K 2,331 at 1.80
0.9%
Not planned
21 Jan 2026
Russell Barton Chief Operating Officer
Sold at will
$4.18K 2,315 at 1.81
1.1%
Not planned
21 Jan 2026
Derek M Meisner Chief Legal Officer & Corp Sec
Sold at will
$4.06K 2,247 at 1.81
1.2%
Not planned
21 Jan 2026
Kristin Abate Chief Accounting Officer
Sold at will
$1.58K 265 at 5.96
1.2%
Not planned
20 Jan 2026
Michael Benkowitz President and COO · indirect
Sold on a plan 28×
$10.45M 22,500 at 464.66
100%
Sold half or more
20 Jan 2026
Brannin McBee Chief Development Officer
Sold on a plan 5×
$9.80M 102,835 at 95.29
29.3%
Planned (10b5-1)
20 Jan 2026
Sanjit Biswas Chief Executve Officer · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
John Bicket See Remarks · indirect
Sold on a plan 6×
$8.56M 263,900 at 32.43
77.0%
Sold half or more
20 Jan 2026
Jennifer L. Wong Chief Operating Officer
Sold on a plan 9×
$6.13M 27,159 at 225.73
2.3%
Planned (10b5-1)
20 Jan 2026
Brannin McBee Chief Development Officer · indirect
Sold on a plan 35×
$6.08M 63,835 at 95.29
100%
Sold half or more
20 Jan 2026
Andrew M Saperstein Co-President
Sold at will 6×
$5.57M 30,330 at 183.62
9.8%
Not planned
20 Jan 2026
Solomon Moshkevich President, Clinicaldiagnostics
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
Daniel Rabinowitz Sec. and Chief Legal Officer
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
John Fesko President, Chief Bus. Officer
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
20 Jan 2026
Eric F Grossman Chief Legal/Admin Officer
Sold at will
$3.97M 21,555 at 184.00
11.2%
Not planned
20 Jan 2026
Kenneth Duda President and CTO
Sold on a plan 4×
$3.85M 30,000 at 128.43
69.8%
Sold half or more
20 Jan 2026
Michael A. Pizzi Head Technology & Operations
Sold at will
$3.69M 20,000 at 184.55
13.5%
Not planned
20 Jan 2026
Kenneth Duda President and CTO · indirect
Sold on a plan 8×
$3.34M 26,000 at 128.43
4.7%
Planned (10b5-1)
20 Jan 2026
Prabir Adarkar President and COO
Sold on a plan 7×
$3.07M 15,000 at 204.59
1.7%
Planned (10b5-1)
20 Jan 2026
Jennifer L. Wong Chief Operating Officer · indirect
Sold on a plan 9×
$2.71M 12,008 at 225.73
19.3%
Planned (10b5-1)
20 Jan 2026
R Stanton Dodge Chief Legal Officer
Sold on a plan 2×
$1.69M 52,777 at 32.01
9.5%
Planned (10b5-1)
20 Jan 2026
Charles A Smith Chief Risk Officer
Sold at will
$1.55M 8,500 at 182.08
6.7%
Not planned
Showing 16,601–16,650 of 20,514. ← Newer Page 333 of 411 Older →